Riskpilot← Back to searchSign inGet full accessMED OSLO AS
ASActiveOrg 899582012Sørkedalsveien 1C, 0369 OsloMedical specialists activities · NACE 8622Est. 20121 employeeswww.medoslo.no
Revenue 2024
NOK 404K
-36% vs 2023
EBITDA margin
-10.7%
+74% vs 2023
Equity ratio
78.4%
Financial strength
Net profit 2024
NOK 3K
+102% vs 2023
| Revenue | NOK 404K | -36% |
| EBITDA | NOK -43K | +74% |
| Net profit | NOK 3K | +102% |
| Total assets | NOK 863K | +143% |
| Equity | NOK 677K | +349% |
| Employees | 1 | — |
Legal name
MED OSLO AS
Org number
899582012
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. oktober 2012
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Medisinsk virksomhet, informasjon, kommunikasjon, forskning og innovasjon innen helse på alle nivåer, samt deltakelse i andre selskaper med liknende virksomheter.
Address
Sørkedalsveien 1C, 0369 Oslo
Phone
+4722500663
Email
post@medoslo.no
Website
www.medoslo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 847 | 2 958 | 2 001 | 629 | 404 |
| Staff expenses | −916 | −653 | −612 | −391 | −56 |
| EBITDA | −80 | 72 | −161 | −166 | −43 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −80 | 72 | −161 | −166 | −43 |
| Net financials | −9 | −27 | −1 | 6 | 5 |
| Profit before tax | −89 | 44 | −162 | −160 | −38 |
| Tax | −0 | −0 | −0 | −0 | −41 |
| Net profit | −89 | 44 | −162 | −160 | 3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 927 | 959 | 694 | 356 | 863 |
| Equity | 429 | 473 | 311 | 151 | 677 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 498 | 486 | 384 | 205 | 187 |
| Total debt | 498 | 486 | 384 | 205 | 187 |
EBITDA margin
-10.7%
This company
15.8%
Market median
-168% vs market
20202024
Equity ratio
78.4%
This company
38.2%
Market median
+105% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MD Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
KD Deputy Member | Deputy Member | 2013 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ullevål Plastikkirugi As
MED OSLO AS Board members of MED OSLO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Drottning-Rønne | Chief Executive Officer | 0 companies |
| Kjell Dagfinn Braathen | Deputy Member | 0 companies |
| Alex Pujari | Chairman | 0 companies |